Bone Remodeling Around HA-coated Acetabular Cups.

Status Completed

Clinical Trial Summary

This study was designed to investigate the influence of HA-coating on bone remodeling around the cup in cementless THA.

100 patients gave informed consent to participate in a controlled randomized study between porous coated Trilogy® versus Trilogy Calcicoat®. The cup was inserted in press-fit fixation. The femoral component was a cementless porous coated titanium alloy stem (Bi-Metric®), with a modular 28 mm CrCo head. Effect parameters were Harris Hip Score (HHS) and Bone Mineral Density (BMD) determined by DEXA scanning.

Measurements revealed no difference between the two groups after 3 years, neither in clinical outcome nor in terms of periprosthetic bone density. Patients with Body Mass Index above normal regained more bone mineral than patients with normal weight. This finding supports the assumption that load is beneficial to bone remodeling. Advantages of better sealing of the bone-prosthesis interface, preventing polyethylene induced osteolysis, may still be anticipated for the 7 or 12 year follow-up examinations

Clinical Trial Description

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00159497
Study type	Interventional
Source	Northern Orthopaedic Division, Denmark
Contact
Status	Completed
Phase	Phase 4
Start date	October 1998
Completion date	January 2011

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01326832` - 10 Year Clinical Evaluation of Primoris Hip Component
Completed	`NCT02399670` - The Influence of Global Femoral-offset Changes After Total Hip Arthroplasty	N/A
Completed	`NCT01046019` - Measurement of Early Bone Loss Around a Total Hip Arthroplasty	N/A
Not yet recruiting	`NCT04570748` - Effect of Capsular Repair on the Outcomes of Direct Anterior Total Hip Arthroplasty.	N/A
Not yet recruiting	`NCT01079455` - Comparison of Hyaluronic Acid and Corticosteroid Intra-articular Injections for the Treatment of Osteoarthritis of the Hip	Phase 3
Completed	`NCT00317889` - Compaction Total Hip Arthroplasty (THA) Bilateral	N/A
Recruiting	`NCT04424628` - Radiotherapy 3 vs 6 Gy in Gonarthrosis and Coxarthrosis	N/A
Not yet recruiting	`NCT06272422` - Comparison of the Restoration of Hip Biomechanical Parameters by CT Measurement Between the 3 Surgical Techniques: RSA/Minihip/THA - Hip Replacement: 3D Planning
Completed	`NCT02694146` - Clinical Trial to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in Coxarthrosis	Phase 3
Completed	`NCT02719236` - Direct Anterior Approach Versus Direct Lateral Approach in Total Hip Arthroplasty	N/A
Completed	`NCT05343195` - Balance and Leg Function After Hip Replacement	N/A
Completed	`NCT01279174` - Galileo-Hip Whole Body Vibration /Conventional Physiotherapy /Coxarthrosis	Phase 4
Active, not recruiting	`NCT00318396` - Compaction Femur Preparation for Cementless Total Hip Arthroplasty (THA) Unilateral	N/A
Completed	`NCT02338596` - Ultra-Short Anatomic and Conventional Cementless Stems Cementless Stems in Patients Younger Than Fifty-Five Years Old	Phase 4
Active, not recruiting	`NCT00722982` - Migration Pattern of C-stem AMT Versus Exeter in Total Hip Arthroplasty	N/A
Completed	`NCT04903860` - Comparison of the Use of Conventional Ancillary Reaming and Single-use Ancillary Reaming Material in Total Hip Replacement	N/A
Recruiting	`NCT04317872` - Effect of Peri-operative Glucocorticoids on Short-term Functional Outcome After THA	N/A
Recruiting	`NCT03809962` - Efficacy and Safety of Ostenil® Plus in the Treatment of Coxarthrosis
Active, not recruiting	`NCT01578746` - Comparison Between Anterior and Direct Lateral Approach in Total Hip Arthroplasty	Phase 4
Completed	`NCT00317863` - Zink and Bone Strength	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.